Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutralizing Antibodies”

193 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 193 results

Testing effectiveness (Phase 2)Study completedNCT00924170
What this trial is testing

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Who this might be right for
Adult T-Cell Leukemia (ATL)
National Cancer Institute (NCI) 18
Not applicableLooking for participantsNCT07085611
What this trial is testing

Neutralizing Power of Serum Antibodies - 2

Who this might be right for
COVID-19SARS-CoV-2 ViraemiaMonkey Pox+3 more
Centre Hospitalier Régional d'Orléans 30
Early research (Phase 1)Study completedNCT03663998
What this trial is testing

Optimising DNA Vaccinations in Healthy Volunteers

Who this might be right for
HIV-1-infection
Imperial College London 36
Testing effectiveness (Phase 2)Study completedNCT03707977
What this trial is testing

Dual bNAb Treatment in Children

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Looking for participantsNCT07655180
What this trial is testing

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Who this might be right for
COVID-19
Invivyd, Inc. 210
Early research (Phase 1)Study completedNCT02824536
What this trial is testing

3BNC117 and 10-1074 in HIV Uninfected Adults

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 24
Early research (Phase 1)Study completedNCT04532294
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Who this might be right for
Covid19
BeiGene 18
Testing effectiveness (Phase 2)Looking for participantsNCT05719441
What this trial is testing

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Who this might be right for
Acute HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02471326
What this trial is testing

VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableUnknownNCT05083026
What this trial is testing

Neutralizing Antibody Level After COVID-19 Vaccination

Who this might be right for
Covid19
Kyungpook National University Hospital 51
Early research (Phase 1)UnknownNCT03588715
What this trial is testing

Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Who this might be right for
HIVHIV/AIDSHIV-1 Infection
Luis Montaner 15
Not applicableStudy completedNCT05158855
What this trial is testing

Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine

Who this might be right for
COVID-19 Pandemic
DreamTec Research Limited 16
Not applicableStudy completedNCT05195060
What this trial is testing

TURN-COVID Biobank: The Dutch Cohort Study for the Evaluation of the Use of Neutralizing Monoclonal Antibodies and Other Antiviral Agents Against SARS-CoV-2

Who this might be right for
COVID-19
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,178
Not applicableStudy completedNCT04545047
What this trial is testing

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
VA Office of Research and Development 5,044
Testing effectiveness (Phase 2)Study completedNCT05683834
What this trial is testing

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Who this might be right for
Epstein-Barr Virus InfectionInfectious MononucleosisHerpesvirus
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT03041012
What this trial is testing

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Who this might be right for
Hiv
Aarhus University Hospital 60
Very early researchStudy completedNCT05110495
What this trial is testing

IGF Inhibition With Xentuzumab Prior to Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Oxford 27
Testing effectiveness (Phase 2)Study completedNCT04871113
What this trial is testing

Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 62
Not applicableStudy completedNCT03893240
What this trial is testing

Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease

Who this might be right for
Pompe DiseasePompe Disease (Late-onset)Glycogen Storage Disease Type 2+3 more
Spark Therapeutics, Inc. 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT07215468
What this trial is testing

HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study

Who this might be right for
HIV -1 Infection
TaiMed Biologics Inc. 88
Next Page